Filing Details
- Accession Number:
- 0001437749-22-028438
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-12-05 17:30:04
- Reporting Period:
- 2022-11-21
- Accepted Time:
- 2022-12-05 17:30:04
- Original Submission Date:
- 2022-11-23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1389545 | Novabay Pharmaceuticals Inc. | NBY | Pharmaceutical Preparations (2834) | 680454536 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1738782 | Jeffrey Kunin | C/O Novabay Pharmaceuticals, Inc. 2000 Powell Street, Suite 1150 Emeryville CA 94608 | President, Dermadoctor, Llc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-21 | 5,960 | $2.10 | 1 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Footnotes
- On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.
- This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The original Form 4, filed on November 23, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that the reporting person beneficially owned no shares following the reported transaction when in fact the reporting person beneficially owned one share following the reported transaction.
- By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.
Billionaire Hedge Funds
